Evidence map›Paper›PMID 39682249›Full record

ArticleCancers2024

Ultrahypofractionated Versus Normofractionated Preoperative Radiotherapy for Soft Tissue Sarcoma: A Multicenter, Prospective Real-World-Time Phase 2 Clinical Trial.

Philip Heesen, Michele Di Lonardo, Olga Ciobanu-Caraus, Georg Schelling, Daniel Zwahlen, Beata Bode-Lesniewska, Christoph Glanzmann, Gabriela Studer, Bruno Fuchs, Swiss Sarcoma Network

Abstract read
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Philip HeesenMedical Faculty, University of Zurich, 8032 Zurich, Switzerland.ORCID 0000-0002-5090-4935
Michele Di LonardoSarcoma Service, Department of Orthopedics and Trauma, Sarcoma Center, Radiation Oncology, LUKS University Hospital, 6000 Luzern, Switzerland.
Olga Ciobanu-CarausFaculty of Medicine, Medical University of Vienna, Spitalgasse 23, 1090 Vienna, Austria.
Georg SchellingSarcoma Service, Department of Orthopedics and Trauma, Sarcoma Center, Radiation Oncology, LUKS University Hospital, 6000 Luzern, Switzerland.
Daniel ZwahlenFaculty of Health Sciences & Medicine, University Lucerne, Frohburgstrasse 3, 6002 Luzern, Switzerland.
Beata Bode-LesniewskaSarcoma Service, Department of Orthopedics and Trauma, Sarcoma Center, Radiation Oncology, LUKS University Hospital, 6000 Luzern, Switzerland.
Christoph GlanzmannSarcoma Service, Department of Orthopedics and Trauma, Sarcoma Center, Radiation Oncology, LUKS University Hospital, 6000 Luzern, Switzerland.
Gabriela StuderSarcoma Service, Department of Orthopedics and Trauma, Sarcoma Center, Radiation Oncology, LUKS University Hospital, 6000 Luzern, Switzerland.ORCID 0000-0001-8780-7701
Bruno FuchsSarcoma Service, Department of Orthopedics and Trauma, Sarcoma Center, Radiation Oncology, LUKS University Hospital, 6000 Luzern, Switzerland.ORCID 0000-0001-6453-3947
Swiss Sarcoma Network

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

clinical triallocal control ratenormofractionated radiotherapy (nRT)preoperative radiation therapysoft tissue sarcomaultrahypofractionated radiotherapy (uhRT)wound complications

Identifiers

PMID39682249
PMCPMC11640059

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.